Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 31, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 31, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 31, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K May 31, 2024 8-K
8-K May 30, 2024 8-K
EFFECT May 24, 2024
CORRESP May 22, 2024
8-K May 20, 2024 8-K
UPLOAD May 16, 2024
S-3 May 9, 2024 S-3
10-Q May 9, 2024 10-Q
8-K May 9, 2024 8-K
ARS Apr 29, 2024 ARS
DEF 14A Apr 29, 2024 DEF 14A
PRE 14A Apr 12, 2024 PRE 14A
SC 13D/A Mar 15, 2024
S-8 Mar 14, 2024 S-8
S-8 Mar 14, 2024 S-8
10-K Mar 14, 2024 10-K
8-K Mar 14, 2024 8-K
8-K Mar 11, 2024 8-K
SC 13G Feb 26, 2024 SC 13G
8-K Feb 16, 2024 8-K
4 Feb 16, 2024
SC 13D/A Feb 16, 2024
← Newer Page 5 of 28 · 693 filings Older →